Skip to main content
MyPeptideMatch logoMyPeptideMatch
Reviewed by MyPeptideMatch Editorial TeamLast reviewed February 2026Updated February 2026

Tirzepatide Dosing Protocol: 15 mg Vial — Week-by-Week Titration & Supplies

Full titration schedule and reconstitution guide for the high-dose 15 mg compounded tirzepatide vial (10 mg/mL).

Go to peptide profileCalculate your dose

Quickstart highlights

At 15 mg weekly, tirzepatide achieved 20.9% mean body weight reduction in SURMOUNT-1 (NCT04184622) — significantly superior to 10 mg (19.5%), 5 mg (16.0%), and semaglutide 2.4 mg (~15%).

  • Concentration: 10 mg/mL (15 mg vial + 1.5 mL bacteriostatic water) — double-strength versus standard vials.
  • At 10 mg/mL: 2.5 mg = 25 units, 5 mg = 50 units, 10 mg = 100 units, 15 mg = 150 units (1.5 mL).
  • SURMOUNT-1 trial: 15 mg dose achieved 20.9% mean body weight reduction at 72 weeks (n=630 in 15 mg arm).
  • One 15 mg vial provides 1 full maintenance dose at 15 mg or multiple lower doses during titration.
  • Double-check unit calculations when switching between 5 mg/mL and 10 mg/mL vials.

Dosing table

For educational reference only. Your prescribing provider may adjust doses based on your clinical profile and response.

WeekDose (µg)UnitsFrequencyNotes
1-4250025Once weekly2.5 mg starting dose — 25 units at 10 mg/mL concentration
5-8500050Once weekly5 mg dose — 50 units; one 15 mg vial covers 3 doses at this level
9-12750075Once weekly7.5 mg dose — 75 units
13-1610000100Once weekly10 mg maintenance — 100 units; one vial provides 1.5 doses
17-2012500125Once weekly12.5 mg — 125 units; one vial provides 1 full dose + 25 units
21+15000150Once weekly15 mg maximum — exactly 1 full vial (1.5 mL) per injection

Reconstitution steps

  1. Draw 1.5 mL bacteriostatic water into a 3 mL syringe; inject slowly down the vial wall.
  2. Gently swirl until lyophilized powder dissolves fully; do not shake or agitate rapidly.
  3. Final concentration: 10 mg/mL (15 mg / 1.5 mL). This is double the concentration of 5 mg/mL vials — verify your units calculation before each dose.
  4. Label vial with reconstitution date; refrigerate at 2–8 °C immediately.

Supplies needed

8-week plan

  • 1 vial
  • 8 syringes
  • 2 mL bac water
  • 8 alcohol swabs

12-week plan

  • 2 vials
  • 12 syringes
  • 3 mL bac water
  • 12 alcohol swabs

16-week plan

  • 2 vials
  • 16 syringes
  • 3 mL bac water
  • 16 alcohol swabs
Need clinics? See vetted providers →

Protocol overview & cycle notes

Advance to the maximum clinical dose of 15 mg weekly for patients who tolerated lower doses and require additional efficacy, using the high-concentration 15 mg vial for single-vial 15 mg injections at maintenance.

Cycle length: 20 weeks on.

Off-cycle: 8–12 weeks off; reassess metabolic parameters and weight trajectory during off-cycle.

Storage & handling

Lyophilized: store below 25 °C. Reconstituted at 10 mg/mL: refrigerate 2–8 °C; use within 28 days. Verify concentration is 10 mg/mL (not 5 mg/mL) before every dose — halve your unit count compared to 5 mg/mL vials.

Injection & tracking tips

  • CRITICAL: This vial reconstitutes to 10 mg/mL — double the typical 5 mg/mL concentration. At 10 mg/mL, 1 unit = 100 µg, not 50 µg. Recalculate units if switching between vial concentrations.
  • Use a 100-unit (1 mL) U-100 syringe; the 15 mg maximum dose requires 1.5 mL (draw into a 3 mL syringe for doses above 10 mg).
  • The 15 mg vial is designed for patients already titrated to high doses; do not start here without prior lower-dose titration.

Tracking

Logging helps you and your provider spot patterns and adjust dose or timing.

  • Record body weight weekly; expect slower weight loss rate at higher doses compared to initial rapid loss.
  • Monitor blood pressure monthly at doses ≥10 mg; tirzepatide may reduce BP as a secondary effect of weight loss.
  • Track muscle mass with DEXA scan or InBody measurements every 8 weeks if available.
Log your cycle in the calculator →

How this works & references

At 15 mg weekly, tirzepatide achieved 20.9% mean body weight reduction in SURMOUNT-1 (NCT04184622) — significantly superior to 10 mg (19.5%), 5 mg (16.0%), and semaglutide 2.4 mg (~15%). The 15 mg dose also reduces HbA1c by 2.58% in type 2 diabetes (SURPASS-2 trial, NCT03987919). Dual GIP/GLP-1 agonism provides additive satiety through independent hypothalamic receptor pathways.

Sources

Frequently asked questions

Why does the 15 mg vial use 10 mg/mL concentration?
Reconstituting 15 mg into 1.5 mL yields 10 mg/mL, allowing a single vial to contain exactly one 15 mg maintenance dose (1.5 mL). This avoids the need to combine from multiple vials at maintenance. Always recalculate units when switching vial concentrations.
Is 15 mg tirzepatide significantly better than 10 mg?
Marginally yes: SURMOUNT-1 showed 20.9% weight loss at 15 mg versus 19.5% at 10 mg — a 1.4% absolute difference. For patients who tolerate 10 mg well, advancing to 15 mg offers modest additional efficacy.
How long should I stay on 15 mg before considering stopping?
Most protocols recommend 12–20 weeks at maximum dose before reassessing. Weight loss plateau typically occurs 8–12 weeks after reaching maintenance. Discuss discontinuation planning with your prescriber.
Can I use a standard 1 mL insulin syringe for the 15 mg dose?
No — 15 mg at 10 mg/mL requires 1.5 mL, which exceeds a standard 1 mL U-100 syringe. Use a 3 mL syringe for the 15 mg dose, drawing to the 1.5 mL mark.
What labs should I monitor on tirzepatide?
Monitor HbA1c, fasting glucose, lipid panel, liver enzymes (ALT/AST), amylase/lipase (pancreatitis screening), and thyroid function (TSH) every 3 months. Blood pressure and heart rate should be checked monthly.

Related protocols

Vilon Dosing Protocol: 20 mg Vial — Dipeptide Immune & Longevity Bioregulator Guide

Vilon (Lys-Glu dipeptide) Russian immune and longevity bioregulator dosing guide — the simplest Khavinson bioregulator for systemic immune normalization and longevity support.

View protocol

Vesugen Dosing Protocol: 20 mg Vial — Vascular Bioregulator & Cardiovascular Guide

Vesugen (Lys-Glu-Asp tetrapeptide) Russian vascular bioregulator dosing guide — endothelial cell gene normalization for arterial health, blood pressure regulation, and cardiovascular aging.

View protocol

Testagen Dosing Protocol: 20 mg Vial — Testicular Bioregulator & Testosterone Support Guide

Testagen (Lys-Glu-Asp-Gly tetrapeptide) Russian testicular bioregulator dosing guide — Leydig cell gene normalization for testosterone production optimization and male reproductive aging support.

View protocol

Prostamax Dosing Protocol: 20 mg Vial — Prostate Bioregulator Guide

Prostamax (Lys-Asp-Glu-Leu tetrapeptide) Russian prostate bioregulator dosing guide — prostatic epithelial gene normalization for BPH, prostate aging, and urinary symptom support.

View protocol

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide therapy. Dosing and protocols may vary by formulation and prescriber.

Need help?

Browse vetted clinicsView full peptide profile →